摘要
目的:探讨肺成纤维细胞(PFC)在博来霉素(BLM)致肺纤维化中的作用机制。方法:采用差时贴壁法培养与纯化PFC,传至第3代备用。分为Control组:细胞用正常的培养基培养;BLM组:依次分为0.01mol/L BLM组、0.03mol/L BLM组、0.1mol/L BLM组、1mol/L BLM组及10mol/L BLM,每组每孔细胞分别加上述浓度的BLM,5×104个PFC/孔(12孔板),干预24小时。TGF-β1组:每个孔用2ug/L TGF-β1,5×104个PFC/孔(12孔板),干预24小时。免疫细胞化学法鉴定PFC与肺肌成纤维细胞(PMFC)。采用Real-time PCR及Western-blot技术检测Ⅰ、Ⅲ型胶原mRNA及α-SMA mRNA表达与α-SMA蛋白水平。Brd U法检测细胞增殖。结果:BLM可剂量依赖性地抑制细胞增殖,BLM浓度从0.1mol/L始抑制PFC的增殖较对照组(P<0.05)。0.1mol/L BLM干预24小时后,α-SMA免疫细胞化学染色鉴定呈阳性,α-SMA mRNA的较对照组表达增加(P<0.05);Ⅰ、Ⅲ型胶原mRNA的表达较对照组显著增加(P<0.01);0.1mol/L BLM能明显升高α—SMA的蛋白表达水平。结论:PFC转化成PMFC且显著增加Ⅰ、Ⅲ型胶原的表达,成为BLM诱导肺纤维化中的重要作用机制之一。
Objective: To study on pulmonary fibroblast cells( PFC) playing an important role of mechanism in causing pulmonary fibrosis induced by Bleomycin( BLM). Methods: Using differential adherent method to cultivate and purify PFC and generating the third to use. The groups were divided into control,0. 01 mol / L BLM,0. 03 mol / L BLM,0. 1mol / L BLM,1mol / L BLM,10 mol / L BLM,2ng / m L TGF-β1. 5× 104 PFC were respectively treated with above drug concentration for 24 hours. PFC and PMFC were identified by immunocytochemistry. Cell proliferation was measured by Brd U marking. The expression of Ⅰ、Ⅲ collagen and α—SMA were analysed by real-time PCR or Western blot. Results: BLM inhibited cell proliferation by dose—dependent from 0. 1 mol / L( P 0. 05 vs Control). Immunocytochemistry staining identification of α-SMA was positive by administrating 0. 1 mol / L BLM for 24 hours. Up-regulated expression of α-SMA,and Ⅰand Ⅲ collagen in induced by BLM. Conclusion: PFC converting into PMFC and up-regulated expression of α-SMA,and Ⅰand Ⅲcollagen induced by BLM become one of the important mechanism of pulmonary fibrosis.
出处
《心肺血管病杂志》
2015年第11期863-866,共4页
Journal of Cardiovascular and Pulmonary Diseases
关键词
肺成纤维细胞
肺肌成纤维细胞
博来霉素
肺纤维化
Pulmonary fibroblast cell
Pulmonary myofibroblast cell
Bleomycin
Pulmonary fibrosis